# Lilly Won the Oral GLP-1 Race. The Market Already Punished It. - Date: 2026-04-06 - Category: Biotech & Life Sciences The FDA cleared Lillys orforglipron in 50 days — fastest new drug approval since 2002. The side effects are 14x worse than Wegovy, and Wall Street just cut its 2026 sales forecast by 60%. ---